SCHEMBL14907753

SCHEMBL14907753

O=C(O)CSc1nnc(-c2cc(O)ccc2O)[nH]1

nearest known ligand 0.60

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
GRK6 P43250 10/20 0.60
GUSB P08236 1/20 0.41
PRKAG1 P54619 3/20 0.40
PRKAB1 Q9Y478 3/20 0.40
PRKAA1 Q13131 2/20 0.40
KMT2A Q03164 3/20 0.39
RAB9A P51151 1/20 0.39
HSD17B10 Q99714 1/20 0.39
KDM4E B2RXH2 1/20 0.37
ALDH1A1 P00352 1/20 0.37
STAT1 P42224 1/20 0.37
PRKAA2 P54646 1/20 0.37
AMY1A P0DUB6 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12180110 0.90 GRK6 (0.59) GRK6PRKAG1PRKAB1PRKAA1KMT2A
SCHEMBL14907893 0.90 GRK6 (0.61) GRK6PRKAG1PRKAB1PRKAA1KMT2A
SCHEMBL18540522 0.88 GRK6 (0.46) GRK6GUSBKMT2ARAB9AKDM4E
SCHEMBL14907819 0.87 GRK6 (0.46) GRK6PRKAG1PRKAB1PRKAA1KMT2A
SCHEMBL14907728 0.87 GRK6 (0.61) GRK6PRKAG1PRKAB1PRKAA1KMT2A
SCHEMBL16171114 0.85 GRK6 (0.45) GRK6PRKAG1PRKAB1PRKAA1KMT2A
SCHEMBL14907755 0.84 GRK6 (0.64) GRK6GUSBKMT2ARAB9AHSD17B10
SCHEMBL14907829 0.83 GRK6 (0.64) GRK6KMT2AKDM4EALDH1A1
SCHEMBL21763996 0.82 GRK6 (0.45) GRK6PRKAG1PRKAB1PRKAA1KMT2A
SCHEMBL14907725 0.80 GRK6 (0.60) GRK6KMT2ARAB9AHSD17B10KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3134390-B1 SMALL MOLECULE INHIBITORS OF G PROTEIN COUPLED RECEPTOR 6 KINASE POLYPEPTIDES MAYO FOUND MEDICAL EDUCATION & RES (US) 2020-02-26 EP disclosed
US-10252984-B2 Inhibiting G protein coupled receptor 6 kinase polypeptides MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) 2019-04-09 US disclosed
US-20170050939-A1 SMALL MOLECULE INHIBITORS OF G PROTEIN COUPLED RECEPTOR 6 KINASE POLYPEPTIDES MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) 2017-02-23 US disclosed
US-20170050939-A1 SMALL MOLECULE INHIBITORS OF G PROTEIN COUPLED RECEPTOR 6 KINASE POLYPEPTIDES MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) 2017-02-23 US disclosed
WO-2015164415-A1 SMALL MOLECULE INHIBITORS OF G PROTEIN COUPLED RECEPTOR 6 KINASE POLYPEPTIDES MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) 2015-10-29 WO disclosed
US-20140309185-A1 Inhibiting G Protein Coupled Receptor 6 Kinase Polypeptides MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH 2014-10-16 US disclosed
US-20140309185-A1 Inhibiting G Protein Coupled Receptor 6 Kinase Polypeptides MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH 2014-10-16 US disclosed
WO-2013063458-A2 INHIBITING G PROTEIN COUPLED RECEPTOR 6 KINASE POLYPEPTIDES MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) 2013-05-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170050939-A1 SMALL MOLECULE INHIBITORS OF G PROTEIN COUPLED RECEPTOR 6 KINASE POLYPEPTIDES GRK6, GRK2, GRK3 GRK6 1/4885GUSB 3302/4885PRKAG1 320/4885
US-20140309185-A1 Inhibiting G Protein Coupled Receptor 6 Kinase Polypeptides GRK6, GRK2, GRK3 GRK6 1/4885GUSB 2509/4885PRKAG1 224/4885
US-10252984-B2 Inhibiting G protein coupled receptor 6 kinase polypeptides GRK6, GRK2, GRK3 GRK6 1/4885GUSB 2509/4885PRKAG1 224/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.